|
1
|
World Health Organization (WHO): Corona
Virus Disease 2019. WHO, Geneva, 2019. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
|
|
2
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han
Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: A descriptive study. Lancet. 395:507–513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Behzad S, Aghaghazvini L, Radmard AR and
Gholamrezanezhad A: Extrapulmonary manifestations of COVID-19:
Radiologic and clinical overview. Clin Imaging. 66:35–41.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
De Sousa Moreira JL, Barbosa SMB, Vieira
JG, Chaves NCB, Felix EBG, Feitosa PWG, da Cruz IS, da Silva CGL
and Neto MLR: The psychiatric and neuropsychiatric repercussions
associated with severe infections of COVID-19 and other
coronaviruses. Prog Neuropsychopharmacol Biol Psychiatry.
106(110159)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mohanty SK, Satapathy A, Naidu MM,
Mukhopadhyay S, Sharma S, Barton LM, Stroberg E, Duval EJ, Pradhan
D, Tzankov A and Parwani AV: Severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) and coronavirus disease 19
(COVID-19)-anatomic pathology perspective on current knowledge.
Diagn Pathol. 15(103)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gao YD, Ding M, Dong X, Zhang JJ, Kursat
Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, et al: Risk factors
for severe and critically ill COVID-19 patients: A review. Allergy.
76:428–455. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Letko M, Marzi A and Munster V: Functional
assessment of cell entry and receptor usage for SARS-CoV-2 and
other lineage B betacoronaviruses. Nat Microbiol. 5:562–569.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y,
Hou C, Wang H, Liu J, Yang D, et al: Role of angiotensin-converting
enzyme 2 (ACE2) in COVID-19. Crit Care. 24(422)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gouda MM and Bhandary YP: IL-17A mediated
downstream changes during acute lung injury. Biochem Mol Biol J.
4(13)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wool GD and Miller JL: The impact of
COVID-19 disease on platelets and coagulation. Pathobiology.
88:15–27. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li
B, Song X and Zhou X: Prognostic value of interleukin-6, C-reactive
protein, and procalcitonin in patients with COVID-19. J Clin Virol.
127(104370)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ponti G, Maccaferri M, Ruini C, Tomasi A
and Ozben T: Biomarkers associated with COVID-19 disease
progression. Crit Rev Clin Lab Sci. 57:389–399. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lagunas-Rangel FA:
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein
ratio in patients with severe coronavirus disease 2019 (COVID-19):
A meta-analysis. J Med Virol. 92:1733–1734. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Francone M, Iafrate F, Masci GM, Coco S,
Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC,
Zingaropoli MA, et al: Chest CT score in COVID-19 patients:
Correlation with disease severity and short-term prognosis. Eur
Radiol. 30:6808–6817. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ahlstrand E, Cajander S, Cajander P,
Ingberg E, Löf E, Wegener M and Lidén M: Visual scoring of chest CT
at hospital admission predicts hospitalization time and intensive
care admission in Covid-19. Infect Dis (Lond). 53:622–632.
2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
World Health Organization (WHO): Clinical
management of severe acute respiratory infection when Middle East
respiratory syndrome corona-virus (MERS-CoV) infection is
suspected: interim guidance. WHO, Geneva, 2019. https://apps.who.int/iris/handle/10665/178529.
|
|
18
|
Diagnosis And treatment protocol for novel
coronavirus pneumonia (Trial Version 7). Chin Med J (Engl).
133:1087–1095. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang
HHX, Luo M, Chen L and Zhao Y: Neutrophil-to-lymphocyte ratio as an
independent risk factor for mortality in hospitalized patients with
COVID-19. J Infect. 81:e6–e12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yang AP, Liu JP, Tao WQ and Li HM: The
diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19
patients. Int Immunopharmacol. 84(106504)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bindoli S, Felicetti M, Sfriso P and Doria
A: The amount of cytokine-release defines different shades of
Sars-Cov2 infection. Exp Biol Med (Maywood). 245:970–976.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ruan Q, Yang K, Wang W, Jiang L and Song
J: Clinical predictors of mortality due to COVID-19 based on an
analysis of data of 150 patients from Wuhan, China. Intensive Care
Med. 46:846–848. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Akhmerov A and Marbán E: COVID-19 and the
Heart. Circ Res. 126:1443–1455. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang
H, Xiong Y, Cheng Z, Gao S, Liang K, et al: Clinical
characteristics of refractory coronavirus disease 2019 in Wuhan,
China. Clin Infect Dis. 73:e4208–e4213. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xia X, Wen M, Zhan S, He J and Chen W: An
increased neutrophil/lymphocyte ratio is an early warning signal of
severe COVID-19. Nan Fang Yi Ke Da Xue Xue Bao. 40:333–336.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
27
|
Simadibrata DM, Calvin J, Wijaya AD and
Ibrahim NAA: Neutrophil-to-lymphocyte ratio on admission to predict
the severity and mortality of COVID-19 patients: A meta-analysis.
Am J Emerg Med. 42:60–69. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bedel C, Korkut M and Armağan HH: NLR,
d-NLR and PLR can be affected by many factors. Int Immunopharmacol.
90(107154)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lippi G and Favaloro EJ: D-dimer is
associated with severity of coronavirus disease 2019: A pooled
analysis. Thromb Haemost. 120:876–878. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pan F, Yang L, Li Y, Liang B, Li L, Ye T,
Li L, Liu D, Gui S, Hu Y and Zheng C: Factors associated with death
outcome in patients with severe coronavirus disease-19 (COVID-19):
A case-control study. Int J Med Sci. 17:1281–1292. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Connors JM and Levy JH: COVID-19 and its
implications for thrombosis and anticoagulation. Blood.
135:2033–2040. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mihaila RG and Dragos Mihaila M:
Coagulation disorders in SARS-CoV-2 infection. Biomed Pap Med Fac
Univ Palacky Olomouc Czech Repub: Sep 9, 2020 (Epub ahead of
print).
|
|
33
|
Taylor FB Jr, Toh CH, Hoots WK, Wada H and
Levi M: Scientific Subcommittee on Disseminated Intravascular
Coagulation (DIC) of the International Society on Thrombosis and
Haemostasis (ISTH). Towards definition, clinical and laboratory
criteria, and a scoring system for disseminated intravascular
coagulation. Thromb Haemost. 86:1327–1330. 2001.PubMed/NCBI
|
|
34
|
Hunt BJ and Levi M: Re The source of
elevated plasma D-dimer levels in COVID-19 infection. Br J
Haematol. 190:e133–e134. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yilmaz A, Sabirli R, Seyit M, Ozen M,
Oskay A, Cakmak V, Goren T and Turkcuer I: Association between
laboratory parameters and CT severity in patients infected with
Covid-19: A retrospective, observational study. Am J Emerg Med.
42:110–114. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tordjman M, Mekki A, Mali RD, Monnier H,
Neveu S, Chassagnon G, Mihoubi F, Carlier N, Marey J, Fournier L,
et al: Determining extent of COVID-19 pneumonia on CT based on
biological variables. Respir Med. 175(106206)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Smilowitz NR, Kunichoff D, Garshick M,
Shah B, Pillinger M, Hochman JS and Berger JS: C-reactive protein
and clinical outcomes in patients with COVID-19. Eur Heart J.
42:2270–2279. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Garbers C, Heink S, Korn T and Rose-John
S: Interleukin-6: Designing specific therapeutics for a complex
cytokine. Nat Rev Drug Discov. 17:395–412. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang
H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological
features of severe and moderate coronavirus disease 2019. J Clin
Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
McElvaney OJ, Hobbs BD, Qiao D, McElvaney
OF, Moll M, McEvoy NL, Clarke J, O'Connor E, Walsh S, Cho MH, et
al: A linear prognostic score based on the ratio of interleukin-6
to interleukin-10 predicts outcomes in COVID-19. EBioMedicine.
61(103026)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lippi G and Plebani M: Procalcitonin in
patients with severe coronavirus disease 2019 (COVID-19): A
meta-analysis. Clin Chim Acta. 505:190–191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Han J, Gatheral T and Williams C:
Procalcitonin for patient stratification and identification of
bacterial co-infection in COVID-19. Clin Med (Lond).
20(e47)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu
Y, Lang C, Huang D, Sun Q, Xiong Y, et al: Clinical features and
treatment of COVID-19 patients in northeast Chongqing. J Med Virol.
92:797–806. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X
and Liu Q: Clinical features and short-term outcomes of 102
patients with coronavirus disease 2019 in Wuhan, China. Clin Infect
Dis. 71:748–755. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ye Z, Zhang Y, Wang Y, Huang Z and Song B:
Chest CT manifestations of new coronavirus disease 2019 (COVID-19):
A pictorial review. Eur Radiol. 30:4381–4389. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Martínez Chamorro E, Díez Tascón A, Ibáñez
Sanz L, Ossaba Vélez S and Borruel Nacenta S: Radiologic diagnosis
of patients with COVID-19. Radiologia (Engl Ed). 63:56–73.
2021.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
47
|
Yuan M, Yin W, Tao Z, Tan W and Hu Y:
Association of radiologic findings with mortality of patients
infected with 2019 novel coronavirus in Wuhan, China. PLoS One.
15(e0230548)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Pfortmueller CA, Spinetti T, Urman RD,
Luedi MM and Schefold JC: COVID-19-associated acute respiratory
distress syndrome (CARDS): Current knowledge on pathophysiology and
ICU treatment-A narrative review. Best Pract Res Clin Anaesthesiol.
35:351–368. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Vafadar Moradi E, Teimouri A, Rezaee R,
Morovatdar N, Foroughian M, Layegh P, Rezvani Kakhki B, Ahmadi
Koupaei SR and Ghorani V: Increased age, neutrophil-to-lymphocyte
ratio (NLR) and white blood cells count are associated with higher
COVID-19 mortality. Am J Emerg Med. 40:11–14. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Asakura H and Ogawa H: COVID-19-associated
coagulopathy and disseminated intravascular coagulation. Int J
Hematol. 113:45–57. 2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Alharthy A, Aletreby W, Faqihi F, Balhamar
A, Alaklobi F, Alanezi K, Jaganathan P, Tamim H, Alqahtani SA,
Karakitsos D and Memish ZA: Clinical characteristics and predictors
of 28-day mortality in 352 critically Ill patients with COVID-19: A
retrospective study. J Epidemiol Glob Health. 11:98–104.
2021.PubMed/NCBI View Article : Google Scholar
|
